Morgan Stanley
-
-
-
-
-
-
-
Moderna shares plunge after cutting research budget
-
-
-
-
-
-
-
Midday movers: Boeing, Apple and more
-
-
-
-
-
-
-
Moderna (MRNA) a catalyst driven idea at Morgan Stanley
-
-
-
-
-
-
-
Moderna (MRNA) Could Offset COVID Revenue via Rare Diseases - Morgan Stanley
-
-
-
-
-
-
-
Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
-
-
-
-
-
-
-
Moderna (MRNA) Shares Could Rally '10-20%' as Morgan Stanley Expects Initial Flu Vaccine Data to be Positive
-
-
-
-
-
-
-
Moderna (MRNA) Announces First Patient Dosed with Booster, Data Could Indicate Increased Supply - Morgan Stanley
-
225,311 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

